• Danielle Jolla, United States says, "I love your online pharmacy Because of your quick shipping and reasonable prices."
  • Jill Barrella, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "I am very satisfied with IDM and plan on making more purchases in the future. IDMs prices are low which makes it very compelling to use over conventional pharmacies with high copays and more restrictions continually implemented."
  • Eric Gonzales, United States says, "The website is very user friendly, there is a lot of variety and checking out was easy."
  • Albert Martinez, United States says, "Very organized and efficient concerning delivery and products are great. Very satisfied, impressed with delivery and product."
  • Natalie Wallace, United States says, "I absolutely love getting my medications at a great price and I always get that here. And I recommend this site to my family and friends."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy Visit to discuss on various diseases and conditions
    Follow us on Twitter

      Watson Pharma Applies To Make Generic Vigamox

      Posted Atbusinessweek.com

      Watson Pharmaceuticals is seeking federal approval to make a generic version of Alcon Inc.'s eye treatment, the company said Friday, just one day after Alcon filed a patent lawsuit against Watson.

      Vigamox treats an eye inflammation called bacterial conjunctivitis. Watson said the antibiotic solution generated $281 million in U.S. sales for the 12 months that ended Feb. 28.

      Watson Pharmaceuticals Inc., headquartered in Corona, Calif., filed an abbreviated new drug application with the Food and Drug Administration. Alcon filed a lawsuit in U.S. District Court to prevent Watson from making and selling the product before its U.S. patents expire. It seeks a stay of final FDA approval for the Watson patent until Sept. 1, 2013.

      April 15, 2011


      Share this Article!

    Back to top^